These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 31618428)

  • 21. [Differential diagnostic distinction between substance-induced and primary psychoses: : Recommendations for general psychiatric and forensic practice].
    Hirjak D; Meyer-Lindenberg A; Brandt GA; Dreßing H
    Nervenarzt; 2022 Jan; 93(1):11-23. PubMed ID: 33656571
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Cannabis and psychosis: search of a causal link through a critical and systematic review].
    Le Bec PY; Fatséas M; Denis C; Lavie E; Auriacombe M
    Encephale; 2009 Sep; 35(4):377-85. PubMed ID: 19748375
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical characteristics of primary psychotic disorders with concurrent substance abuse and substance-induced psychotic disorders: A systematic review.
    Wilson L; Szigeti A; Kearney A; Clarke M
    Schizophr Res; 2018 Jul; 197():78-86. PubMed ID: 29117908
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Isosafrole and schizophrenia-like psychosis.
    Keitner GI; Sabaawi M; Haier RJ
    Am J Psychiatry; 1984 Aug; 141(8):997-8. PubMed ID: 6465379
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Psychotic disorders among inpatients with abuse of cannabis, amphetamine and opiates. Do dopaminergic stimulants facilitate psychiatric illness?
    Dalmau A; Bergman B; Brismar B
    Eur Psychiatry; 1999 Nov; 14(7):366-71. PubMed ID: 10683620
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hallucinogenic drugs as precipitants of schizophrenia.
    Breakey WR; Goodell H; Lorenz PC; McHugh PR
    Psychol Med; 1974 Aug; 4(3):255-61. PubMed ID: 4427973
    [No Abstract]   [Full Text] [Related]  

  • 27. Substance misuse and early psychosis.
    Tucker P
    Australas Psychiatry; 2009 Aug; 17(4):291-4. PubMed ID: 19301164
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differences in associations between cannabis and stimulant disorders in first admission psychosis.
    Sara G; Burgess P; Malhi GS; Whiteford H; Hall W
    Schizophr Res; 2013 Jul; 147(2-3):216-22. PubMed ID: 23684162
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Differential diagnosis and syndrome-genetic problems and aspects of drug-induced psychoses in juveniles (author's transl)].
    Bron B; Fröscher W; Gehlen W
    Fortschr Neurol Psychiatr Grenzgeb; 1976 Dec; 44(12):673-82. PubMed ID: 1051411
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cannabis use and transition to psychosis in people at ultra-high risk.
    Valmaggia LR; Day FL; Jones C; Bissoli S; Pugh C; Hall D; Bhattacharyya S; Howes O; Stone J; Fusar-Poli P; Byrne M; McGuire PK
    Psychol Med; 2014 Sep; 44(12):2503-12. PubMed ID: 25055169
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Atypical antipsychotics for psychosis in adolescents.
    Kumar A; Datta SS; Wright SD; Furtado VA; Russell PS
    Cochrane Database Syst Rev; 2013 Oct; 2013(10):CD009582. PubMed ID: 24129841
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Psychosis induced by amphetamines.
    Bramness JG; Rognli EB
    Curr Opin Psychiatry; 2016 Jul; 29(4):236-41. PubMed ID: 27175554
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cannabis abuse and risk for psychosis in a prodromal sample.
    Kristensen K; Cadenhead KS
    Psychiatry Res; 2007 May; 151(1-2):151-4. PubMed ID: 17383738
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Meta-analysis of the Association Between the Level of Cannabis Use and Risk of Psychosis.
    Marconi A; Di Forti M; Lewis CM; Murray RM; Vassos E
    Schizophr Bull; 2016 Sep; 42(5):1262-9. PubMed ID: 26884547
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Drug-induced psychosis.
    Abruzzi W
    Int J Addict; 1977 Feb; 12(1):183-93. PubMed ID: 863562
    [No Abstract]   [Full Text] [Related]  

  • 36. Stimulant use disorders in people with psychosis: a meta-analysis of rate and factors affecting variation.
    Sara GE; Large MM; Matheson SL; Burgess PM; Malhi GS; Whiteford HA; Hall WD
    Aust N Z J Psychiatry; 2015 Feb; 49(2):106-17. PubMed ID: 25518844
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cannabis-induced attenuated psychotic symptoms: implications for prognosis in young people at ultra-high risk for psychosis.
    McHugh MJ; McGorry PD; Yung AR; Lin A; Wood SJ; Hartmann JA; Nelson B
    Psychol Med; 2017 Mar; 47(4):616-626. PubMed ID: 27821204
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Substance-induced Psychosis in Youth.
    Beckmann D; Lowman KL; Nargiso J; McKowen J; Watt L; Yule AM
    Child Adolesc Psychiatr Clin N Am; 2020 Jan; 29(1):131-143. PubMed ID: 31708042
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Psychosis among substance users.
    Thirthalli J; Benegal V
    Curr Opin Psychiatry; 2006 May; 19(3):239-45. PubMed ID: 16612208
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Addiction and schizophrenia. Nosological, clinical and therapeutic questions. 2. Substance dependence and schizophrenia].
    Soyka M
    Fortschr Neurol Psychiatr; 1994 Jun; 62(6):186-96. PubMed ID: 8050773
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.